Amendment of Lock-up terms

Sinclair IS Pharma plc

Amendment of Lock-up terms

Sinclair IS Pharma plc (AIM:SPH.L) ("Sinclair IS" or the "Company"), the international specialty pharma company, announces that in order to satisfy institutional demand, it has amended the terms of the lock-up arrangements with the ex-shareholders of Advanced Bio-Technologies Inc.

The final 8,511,864 ordinary shares issued as consideration have now been released and placed with investors. There are no further ordinary shares subject to lock-up arrangements.

Ends

For further information please contact:

Sinclair IS Pharma plc Tel: +44 (0) 20 7467 6920

Chris Spooner

Alan Olby

Robert Taylor

Peel Hunt LLP Tel: +44 (0) 20 7418 8900

James Steel

Vijay Barathan

Notes to Editors:

About Sinclair IS Pharma plc - www.sinclairispharma.com 

Sinclair IS Pharma is an international specialty pharmaceutical company focused on treatments in dermatology, wound care, oncology support and critical care through advanced surface technology and innovative delivery systems. The Company has a growing sales and marketing operation with a direct sales presence in the top five European markets and an extensive marketing partner network across selected developed and emerging markets.